stockrow
Saturday 7 November 2026
Export DCGO’s income statement to Excel — free account
DocGo Inc.
DCGO Healthcare Medical Care Facilities
DocGo Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.2 million, down 47.7% from fiscal 2024.
- Revenue
- −8.70%
- EPS
- −45.5%
- Free cash flow
- −132.3%
- Total debt
- +7,140.9%
Quarter to June 2026, against a year earlier
0.25
0.01
+4.17%
Follow DCGO
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.17 | 0.21 | 0.27 | 0.36 | |
P/FCF ratio |
0.00 | 4.47 | 3.20 | 2.55 | |
P/Operating CF |
(5.56) | (13.36) | (8.33) | 80.19 | |
P/B ratio |
0.54 | 0.56 | 0.69 | 0.51 | |
Price to Tangible BV |
0.54 | 0.56 | 1.30 | 0.66 | |
EV/Sales |
0.09 | 0.09 | 0.11 | 0.16 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.16) | 1.30 | 1.06 | 1.04 | |
EV/FCF |
(0.92) | 1.92 | 1.34 | 1.15 | |
Quick Ratio |
1.54 | 1.68 | 2.13 | 2.45 | |
Current Ratio |
1.66 | 1.79 | 2.26 | 2.59 | |
Net Debt/EBITDA |
1.65 | 2.21 | 0.99 | 2.50 | |
Debt/Assets |
0.09% | 0.08% | 0.08% | 0.06% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.99 | 0.94 | 0.96 | 0.87 | |
Operating CF/Net income |
0.58 | 0.32 | 0.08 | (0.06) | |
Capex/Depreciation |
(0.42) | (0.41) | (0.04) | (0.12) | |
Interest Coverage |
(183.63) | (187.67) | (686.22) | (190.89) | |
Research and Development Expense of Revenue |
4.69% | 4.90% | 5.03% | 4.51% | |
Selling, General and Administrative Expense of Revenue |
41.08% | 41.31% | 52.79% | 43.03% | |
Intangible Assets out of Total Assets |
0.01 | 0.00 | 0.00 | 0.17 | |
Share Based Compensation of Revenue |
3.62% | 4.27% | 4.18% | 6.57% | |
Graham Net Nets |
0.56 | 0.65 | 0.70 | 0.73 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(376.92%) | (303.17%) | (210.23%) | (37.50%) | |
Free Cash Flow Yield |
(55.61%) | 22.37% | 31.22% | 39.19% | |
Revenue per Share |
0.74 | 0.77 | 0.76 | 0.72 | |
Operating CF per Share |
(0.09) | (0.05) | (0.11) | 0.02 | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.02) | |
Free Cash Flow per Share |
(0.10) | (0.06) | (0.13) | 0.00 | |
Cash per Share |
0.26 | 0.36 | 0.52 | 0.75 | |
Shareholders Equity per Share |
0.97 | 1.13 | 1.27 | 2.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.97 | 1.13 | 1.27 | 2.67 | |
Free Cash Flow |
(10.37) | (5.73) | (12.59) | 0.12 | |
Working Capital |
47.46 | 60.95 | 84.91 | 116.64 | |
Capital Expenditures |
(1.13) | (1.07) | (2.12) | (1.54) | |
Net Current Asset Value |
28.76 | 40.15 | 61.17 | 97.11 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.01 | 0.03 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
104.49 | 136.36 | 151.90 | 170.36 | |
Average Payables |
12.07 | 17.19 | 19.73 | 21.60 | |
Average Assets |
297.54 | 320.01 | 336.36 | 423.83 | |
Average Common Equity |
191.76 | 206.57 | 220.53 | 292.78 |
Columns are period end dates